E-E-A-T Verified Evidence-Based Men's Vitality Portal — Published by WERQUIN ANTOINE (SIREN: 788 848 646 • Bailleul, France). Non-commercial open-access database.
Editorial Board & Institutional Governance

About Menvital & Our Scientific Charter

Eliminating commercial bias in male micronutrition through transparent peer review, rigorous biochemical standards, and strict French corporate accountability.

Our Founding Mission

Menvital was established by Antoine Werquin under the French legal business WERQUIN ANTOINE (SIREN: 788 848 646) headquartered in Bailleul, Hauts-de-France.

In an industry saturated with proprietary "underdosed blends", exaggerated marketing claims, and unverified anecdotal trends, Menvital serves as an uncompromising, open-access repository of clinical male biochemistry.

Every protocol, dynamic calculator, and nutrient interaction model is engineered strictly from randomized double-blind clinical trials (RCTs), European Food Safety Authority (EFSA) scientific opinions, and published peer-reviewed journals.

Official Corporate Identity

Company Name: WERQUIN ANTOINE
Founder: Antoine Werquin
SIREN (siège): 788 848 646
Registration Date: 28/07/2012
Location: 34 Rue d'Occident, 59270 Bailleul
Jurisdiction: France / European Union

Our Three Core Scientific Principles

  • 1. Absolute Bioavailability: We prioritize chelated minerals (Bisglycinates) and methylated vitamins over cheap, non-absorbable oxides and sulfates.
  • 2. Non-Commercial Objectivity: We do not sell proprietary supplement bottles or enter private white-label partnerships.
  • 3. Chronobiological Precision: We integrate circadian timing to ensure lipophilic vitamins and parasympathetic minerals are taken when their cellular absorption is highest.

Our 4-Step Clinical Review Standard

How our research staff in Bailleul, France audits, updates, and verifies every published guideline.

Step 01

PubMed & Meta-Analysis Screen

We extract human clinical trials, systematic reviews, and pharmacokinetic data from peer-reviewed databases.

Step 02

EFSA & Safety Threshold Check

Dosages are cross-referenced against Tolerable Upper Intake Levels (UL) established by European and international bodies.

Step 03

Co-Factor Synergy Audit

We evaluate competitive intestinal transport mechanisms (e.g. Zinc/Copper ratio, Calcium/Magnesium separation).

Step 04

Annual Clinical Revision

All guides undergo periodic revisions as new prospective cohort data and biomarker trials emerge.